HEATHER HODGSON: Open Payments
NPI 1366682494 · HARRISON, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,333 in 69 payments from 13 companies in 2025. Trend: 2023 $1,074 · 2024 $1,516 · 2025 $1,333
Food & beverage: $1,333
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $198 |
| Alkermes, Inc. | 11 | $197 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $191 |
| Neurocrine BioSciences, Inc. | 7 | $160 |
| Otsuka America Pharmaceutical, Inc. | 9 | $154 |
| Vanda Pharmaceuticals Inc. | 4 | $120 |
| Lundbeck LLC | 4 | $83 |
| Teva Pharmaceuticals USA, Inc. | 4 | $79 |
| Axsome Therapeutics, Inc. | 2 | $40 |
| Supernus Pharmaceuticals, Inc. | 2 | $35 |
Products named: REXULTI, VRAYLAR, ARISTADA, CAPLYTA, INGREZZA, FANAPT, AUSTEDO XR, Auvelity.
Industry payments across AR — which companies pay providers there.
